MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion.
Herein, when did AstraZeneca buys MedImmune?
Furthermore, where is MedImmune located?
1 Medimmune Way, Gaithersburg
What happened to MedImmune?
MedImmune will cease to exist after 30 years AZ acquired MedImmune in 2007 for $15.2bn (€13.42bn), boosting the company's pipeline of biologic medicine candidates. In announcing the retirement of the MedImmune brand, the subsidiary stated that nearly half of AZ's current pipeline is made of biologics.
What drugs do AstraZeneca make?
- Accolate (zafirlukast)
- Bambec (bambuterol)
- Bricanyl (terbutaline)
- Daliresp (roflumilast)
- Fasenra (benralizumab)
- Oxis (formoterol)
- Pulmicort/Rhinocort (budesonide)
- Symbicort (budesonide/formoterol)